Genfit S.A. buy BiotechBee
Start price
10.12.23
/
50%
€3.32
Target price
31.05.25
€4.90
Performance (%)
5.43%
End price
17.02.24
€3.50
Summary
This prediction ended on 17.02.24 with a price of €3.50. The BUY prediction by BiotechBee finished with a performance of 5.43%. BiotechBee has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Genfit S.A. | 9.987% | 9.987% | 43.137% |
| iShares Core DAX® | 0.734% | -0.964% | 17.910% |
| iShares Nasdaq 100 | -2.686% | -2.409% | 4.267% |
| iShares Nikkei 225® | -2.261% | -4.038% | 10.420% |
| iShares S&P 500 | -1.346% | -1.510% | 1.615% |
According to BiotechBee what are the pros and cons of Genfit S.A. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Genfit S.A. diskutieren
In the thread Trading Genfit S.A.
Stopped prediction by BiotechBee for Genfit S.A.
Genfit S.A.
Start price
Target price
Perf. (%)
€3.56
27.06.23
27.06.23
€1.50
31.01.26
31.01.26
-19.10%
20.10.23
20.10.23
Could be very worthwhile Investment >20% year
